MedPath

The Effect of Anaesthetic Drugs on Recovery in Patients Undergoing Cancer surgery

Not Applicable
Completed
Conditions
Health Condition 1: null- GASTRO INTESTINAL MALIGNANCY SURGERIES
Registration Number
CTRI/2018/02/011880
Lead Sponsor
All India Institute of Medical Sciences Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
84
Inclusion Criteria

All adults patients between 18 to 70 years undergoing open GI malignancy surgeries of American Society of Anesthesiologists I & II

Surgeries that are expected to last less than 6 hrs

Exclusion Criteria

Refusal for the consent

Emergency surgeries and re-do surgeries

Patients having any coagulopathies

Diabetic patients

Contraindications to dexmedetomidine and ketamine

Contraindications to epidural

Patients who has received these drugs previously within one month

Known allergic to ketamine and dexmedetomidine.

Patients not extubated for >6 hrs after reversal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To assess the effect of infusion of a low dose of ketamine and dexmedetomidine infusions vs placebo on the time to passage of first flatus and/or stools in patients undergoing GI malignancy surgeries.Timepoint: Post - Operatively 24 hrs to 72 hrs
Secondary Outcome Measures
NameTimeMethod
1.Total intra-operative & post-operative analgesic used (fentanyl & epidural) <br/ ><br>2.Post op pain & PONV <br/ ><br>3.Duration of ICU stay & time to hospital discharge <br/ ><br>4.Time to extubation after reversal <br/ ><br>5.Any other adverse eventsTimepoint: post-operatively upto 48 hrs
© Copyright 2025. All Rights Reserved by MedPath